Sellas Life Sciences faces high risk in the Phase 3 REGAL AML trial for GPS. Click here to know why I rate the SLS stock a ...

The road to commercializing a life sciences product is a long one, spanning years to perform research, develop the product, conduct clinical trials and testing, and receive approval from the Food and ...

October 09, 2025 - Big Pharma continues its hunt for innovation, and with uncertain market and regulatory conditions, some life sciences companies may be feeling the pressure to make their M&A exit or ...

Given the typically long and costly product development, review, and approval timelines, relative regulatory stability from the FDA has served in many ways to encourage investment in medical product ...

Life sciences organizations are highly visible and active across established media channels, but discoverability represents ...